FRANKFURT, May 6 (Reuters) - Diversified holding company Franz Haniel & Cie. said it has no plans to further reduce its stake in German drugs distributor Celesio, rebuffing a media report.
Stock market newsletter Platow Brief earlier reported that Haniel Chief Executive Stephan Gemkow was considering slashing its holding in Celesio to just above 25 percent.
A Haniel spokesman said there were no such plans nor talks.
Haniel in November sold a 4.6 percent stake in Celesio to reduce its debt burden, cutting its stake to 50.01 percent. (Reporting by Matthias Inverardi and Daniela Pegna; Writing by Ludwig Burger)